Pangenomics International Private Limited

Pangenomics International Private Limited - healthcare in Ahmedabad, Gujarat, India. Directors, charges & compliance details.
CIN U85110GJ2014PTC080226 Incorporated 25 July 2014 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Merged Private Limited Company healthcare
Revenue · FY 2022
₹20.49 Cr
▼ 8% YoY
Net profit · FY 2022
₹6.62 Cr
Net margin 32.3%
EBITDA · FY 2022
₹10.11 Cr
EBITDA margin 49.3%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹6.7 Cr
Issued & subscribed
Company age
12 yrs
Est. 2014
Employees · EPFO
15
Provident fund records
Directors on board
3
As per MCA filings

About Pangenomics International Private Limited

Data last updated:

Pangenomics International Private Limited was a private limited company based in Ahmedabad, Gujarat, India, operated as a subsidiary of Sterling Accuris Wellness Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 25 July 2014.

The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U85110GJ2014PTC080226. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹8 Cr and a paid-up capital of ₹6.7 Cr. It was led by directors including Rajiv Sharma and Ashish Shrimal.

Its last annual general meeting (AGM) was held on 28 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at Shop No.108 109 First Floor Sankalp Square – II Opp. Jalaram Mandir Ellisbridge, Ahmedabad, Gujarat, India – 380006.

As per the financials filed for FY 2022, the company reported a revenue of ₹20.49 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹6.62 Cr (net margin 32.3%) and EBITDA of ₹10.11 Cr (EBITDA margin 49.3%). Revenue has grown at a compounded annual rate (CAGR) of 146% over three years.

The company had about 15 employees on its provident fund (EPFO) records before it was dissolved.

The company was associated with 1 brand: Sterling Accuris Diagnostics. Court records list 8 cases involving the company, including 7 filed by the company and 1 filed against it; 2 cases are pending. The company has 6 deals on record (3 rights issues, 2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹4.75 Cr; the latest was in September 2018. Its 4 peer companies in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities) are compared by revenue, 4 larger; the largest is Model Medi Diagnostic Centre Private Limited with revenue of ₹20.92 Cr. The company has 7 MSME Form 1 returns on record between 2019 and 2022, listing 27 overdue payments to 6 micro and small suppliers.

The last known website on record is pangenomics.in.

Company details

CIN U85110GJ2014PTC080226
Registration Number 080226
Incorporation Date 25 July 2014
ROC Ahmedabad
Listing Status Unlisted
Company Status Amalgamated
Parent Company Sterling Accuris Wellness Private Limited
Compliance Status Active Compliant

Contact details

Pangenomics International Private Limited's registered office is in Ahmedabad, Gujarat. Its website is pangenomics.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Shop No.108 109 First Floor Sankalp Square – II Opp. Jalaram Mandir Ellisbridge, Ahmedabad, Gujarat, India – 380006
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs

To see the full contact details of Pangenomics International Private Limited, buy the company report.

Comprehensive company report
Pangenomics International Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Pangenomics International operates one associated brand: Sterling Accuris Diagnostics. Each brand links to its own profile.

BrandDescriptionWebsite
Pathology diagnostic services are offered via a chain of labs.sterlingaccuris.com

Business activity

The main business activity of Pangenomics International is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Pangenomics International Private Limited, buy the company report.

Financials of Pangenomics International Private Limited

FY 2022 filings available

Pangenomics International Private Limited reported revenue of ₹20.49 Cr (down 8% YoY) for FY 2022.

Revenue · FY 2022
₹20.49 Cr ▼ 8%
Net profit · FY 2022
₹6.62 Cr margin 32.3%
EBITDA · FY 2022
₹10.11 Cr margin 49.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 146%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 101%

Revenue fell 8% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 146%. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹20.49 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.11 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.62 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin49.3%
Net Profit Margin32.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Pangenomics International Private Limited, buy the company report.

Board of directors of Pangenomics International Private Limited

Pangenomics International has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Rajiv SharmaDirector07 Jul 201610 Years 4 MonthsAs last reported
Ashish ShrimalDirector01 Oct 20188 Years 1 MonthsAs last reported
Girishbhai Naranbhai PatelDirector07 Jul 201610 Years 4 MonthsAs last reported

Peer comparison

Pangenomics International Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Model Medi Diagnostic Centre Private Limited₹20.92 Cr (FY 2025)9.0%Ernakulam, Kerala, India
PRL Diagnostics Private Limited₹20.75 Cr (FY 2025)46.0%Delhi, India
Arth Diagnostic Private Limited₹20.64 Cr (FY 2024)4.0%Udaipur, Rajasthan, India
Janta X Ray Clinic Private Limited₹20.52 Cr (FY 2025)0.0%New Delhi, Delhi, India
Pangenomics International Private Limitedthis company₹20.49 Cr (FY 2022)₹6.62 Cr32.3%-8.0%15Ahmedabad, Gujarat, India

To see the full peer comparison of Pangenomics International Private Limited, buy the company report.

Auditor

Pangenomics International Private Limited is audited by Chandulal M. Shah for the financial year 2022.

Auditor firmFinancial yearFirm registration number
Chandulal M. ShahFY 2022101698W

Shareholding

The shareholding of Pangenomics International Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Pangenomics International Private Limited, buy the company report.

Deals & funding

Pangenomics International Private Limited has 6 deals on record (3 rights issues, 2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹4.75 Cr; the latest was in September 2018.

Total deals
6
Rights issues
3
Funding rounds
2
Secondary share transfer
1
Disclosed funding
₹4.75 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Sep 2018Secondary share transferUndisclosedBuyer: Sterling Accuries Wellness Private Limited
Seller: 2 individuals
Mar 2017Rights issue₹4.11 CrInvestors: Sterling Accuries Wellness Private Limited, 2 individuals
Apr 2016Funding round₹4.31 CrInvestors: Sterling Accuries Wellness Private Limited
Aug 2015Rights issue₹63.3 LakhInvestors: 2 individuals
Mar 2015Funding round₹43.7 LakhInvestors: 2 individuals

To see the full deal history of Pangenomics International Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Pangenomics International Private Limited has 7 MSME Form 1 returns on record between 2019 and 2022, listing 27 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 6)

SupplierAmount dueDue sinceReported on
Genetix Biotech Asia Limited
an individual supplier
an individual supplier
an individual supplier
an individual supplier

To see the full MSME payment records of Pangenomics International Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Pangenomics International Private Limited has a workforce of 15 employees on its EPFO records as of Oct 2022, across 1 active EPFO establishment.

Employee count
15
Active EPFO establishments
1
Employee growth
-40%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2022-2315
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Pangenomics International Private Limited, buy the company report.

GST

Pangenomics International has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Pangenomics International Private Limited, buy the company report.

Recent activity

Pangenomics International Private Limited has 10 board changes on record since 2016: 3 appointments and 7 cessations. The latest: Ashish Shrimal ceased to be Additional Director on 25 Sep 2019.

AGM
Pangenomics International Private Limited last Annual general meeting of members was held on 28 Sep 2022 as per latest MCA records.
Filing
Pangenomics International Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Ahmedabad.
Ceased
Ashish Shrimal ceased to be Additional Director.
Appointed
Ashish Shrimal was appointed as Director.
Ceased
Santu Dilipkumar Dhar ceased to be Alternate Director.
Ceased
Shweta Utpal Dhar ceased to be Director.
Ceased
Utpal Dilipkumar Dhar ceased to be Director.
Ceased
Girishbhai Naranbhai Patel ceased to be Additional Director.
Ceased
Rajiv Sharma ceased to be Additional Director.
Ceased
Dilipkumar Parimalchandra Dhar ceased to be Director.
Appointed
Girishbhai Naranbhai Patel was appointed as Director.
Appointed
Rajiv Sharma was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Pangenomics International has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Pangenomics International was a private limited company based in Ahmedabad, Gujarat, India. The company worked in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 25 July 2014 and is registered under CIN U85110GJ2014PTC080226. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.

Pangenomics International was incorporated on 25 July 2014. It is registered with the Registrar of Companies, Ahmedabad.

Pangenomics International had 3 directors:

The CIN (Corporate Identification Number) of Pangenomics International is U85110GJ2014PTC080226. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Pangenomics International is at Shop No.108 109 First Floor Sankalp Square – II Opp. Jalaram Mandir Ellisbridge, Ahmedabad, Gujarat, India – 380006.

Pangenomics International can be reached through the website pangenomics.in. Its registered office is in Ahmedabad, Gujarat, India.

The latest financial statements of Pangenomics International on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 28 September 2022. Year-wise statements from 2015 are in the company report.

No. Pangenomics International has 1 GST registration on record and it is cancelled or inactive.

Pangenomics International operated in the healthcare industry, in the diagnostic centers and pathology labs segment.

Pangenomics International has 6 deals on record (3 rights issues, 2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹4.75 Cr; the latest was in September 2018.

The peers of Pangenomics International by revenue are Model Medi Diagnostic Centre Private Limited, PRL Diagnostics Private Limited, Arth Diagnostic Private Limited, Janta X Ray Clinic Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).